GI
LEGN icon

GAMMA Investing’s Legend Biotech LEGN Stock Holding History

GAMMA Investing’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.3K Buy
619
+3
+0.5% +$64 ﹤0.01% 3233
2026
Q2 		$17.8K Buy
616
+241
+64% +$6.5K ﹤0.01% 2896
2026
Q1 		$6.78K Buy
375
+317
+547% +$6.04K ﹤0.01% 3248
2025
Q4 		$1.26K Sell
58
-1,095
-95% -$31.4K ﹤0.01% 3728
2025
Q3 		$37.6K Buy
1,153
+308
+36% +$11.4K ﹤0.01% 2169
2025
Q2 		$30K Sell
845
-446
-35% -$14.5K ﹤0.01% 2251
2025
Q1 		$43.8K Buy
1,291
+765
+145% +$27.4K ﹤0.01% 1884
2024
Q4 		$17.1K Buy
526
+104
+25% +$4.31K ﹤0.01% 2351
2024
Q3 		$20.6K Buy
422
+167
+65% +$8.89K ﹤0.01% 2088
2024
Q2 		$11.3K Buy
255
+77
+43% +$3.55K ﹤0.01% 2184
2024
Q1 		$9.98K Buy
178
+113
+174% +$6.82K ﹤0.01% 2071
2023
Q4 		$3.58K Buy
+65
New +$4.12K ﹤0.01% 2373

Other funds holding LEGN

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

GAMMA Investing's LEGN Position: Q3 2026 in Review

GAMMA Investing increased its Legend Biotech (LEGN) stake by 0.49% in Q3 2026, buying an estimated $64 and bringing the position to 619 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3233.

GAMMA Investing first reported a position in LEGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $43.8K in Q1 2025. 5 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • GAMMA Investing held 619 shares of Legend Biotech worth $12.3K as of Q3 2026.
  • GAMMA Investing bought 3 Legend Biotech shares in Q3 2026, an estimated $64.
  • Legend Biotech made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3233 holding.
  • GAMMA Investing first reported a position in Legend Biotech in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Legend Biotech position peaked at $43.8K in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.